[144] Apellis Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

James G. Chopas filed a Rule 144 notice to sell 726 common shares of the issuer. The planned sale is to be executed through Fidelity Brokerage Services LLC on NASDAQ, with an approximate aggregate market value of $14,369.65 and an approximate sale date of 01/20/2026. The shares to be sold were acquired on 01/16/2026 through restricted stock vesting as compensation from the issuer. The notice also reports that the issuer had 126,525,218 shares outstanding. During the past three months, Chopas previously sold 873 common shares for gross proceeds of $19,369.43.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	726	14369.65	126525218	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/16/2026	Restricted Stock Vesting	Issuer			726	01/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James G. Chopas 100 Fifth Avenue Waltham MA 02451	Common	01/13/2026	873	19369.43

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for APLS report?

The Form 144 reports that James G. Chopas intends to sell 726 common shares of the issuer under Rule 144, using Fidelity Brokerage Services LLC to execute the sale on NASDAQ.

How many APLS shares does James G. Chopas plan to sell and at what value?

He plans to sell 726 common shares with an indicated aggregate market value of $14,369.65, according to the Rule 144 notice.

When were the APLS shares being sold under Form 144 acquired and how?

The 726 common shares were acquired on 01/16/2026 through restricted stock vesting from the issuer, described as compensation in the filing.

On which exchange and through which broker are the APLS shares expected to be sold?

The planned sale is listed for execution on the NASDAQ exchange through Fidelity Brokerage Services LLC, with an approximate sale date of 01/20/2026.

How many issuer shares were outstanding according to the Form 144 for APLS?

The notice states that the issuer had 126,525,218 shares of the relevant class outstanding at the time referenced in the filing.

What other APLS share sales by James G. Chopas were disclosed for the past 3 months?

The filing discloses that on 01/13/2026, James G. Chopas sold 873 common shares of the issuer for gross proceeds of $19,369.43.

What representation does the seller make in the APLS Form 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, and this also applies as of any disclosed Rule 10b5-1 plan adoption or instruction date.